Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 8, 2012 - Issue 2
Submit an article Journal homepage
149
Views
19
CrossRef citations to date
0
Altmetric
Drug Profile

Chronotherapy with modified-release prednisone in patients with rheumatoid arthritis

Rieke Alten Department of Internal Medicine II, Rheumatology, Clinical Immunology & Osteology, Schlosspark-Klinik Teaching Hospital Charité University Medicine Berlin, Heubnerweg 2, 14059 Berlin, Germany. [email protected]
Pages 123-133 | Published online: 10 Jan 2014

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Stefano Paolo Beltrametti, Aurora Ianniello & Clara Ricci. (2016) Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review. Therapeutics and Clinical Risk Management 12, pages 1763-1776.
Read now
William Dunlop, Itrat Iqbal, Ifty Khan, Mario Ouwens & Louise Heron. (2013) Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference values. ClinicoEconomics and Outcomes Research 5, pages 555-564.
Read now
Olivier Ethgen, Frédéric de Lemos Esteves, Olivier Bruyere & Jean-Yves Reginster. (2013) What do we know about the safety of corticosteroids in rheumatoid arthritis?. Current Medical Research and Opinion 29:9, pages 1147-1160.
Read now
Frank Buttgereit & Allan Gibofsky. (2013) Delayed-release prednisone – a new approach to an old therapy. Expert Opinion on Pharmacotherapy 14:8, pages 1097-1106.
Read now

Articles from other publishers (15)

Shigehiro Ohdo, Satoru Koyanagi & Naoya Matsunaga. (2022) Chronopharmacology of immune-related diseases. Allergology International 71:4, pages 437-447.
Crossref
Shigehiro Ohdo. (2021) Chrono-Drug Discovery and Development Based on Circadian Rhythm of Molecular, Cellular and Organ Level. Biological and Pharmaceutical Bulletin 44:6, pages 747-761.
Crossref
Shigehiro Ohdo, Satoru Koyanagi & Naoya Matsunaga. (2019) Chronopharmacological strategies focused on chrono-drug discovery. Pharmacology & Therapeutics 202, pages 72-90.
Crossref
Chi Chiu Mok, Hoon Suk Cha, Rudy Hidayat, Lan Thi Ngoc Nguyen, Emmanuel C. Perez, Raveendran Ramachandran, Gregory J. Tsay & Dae Hyun Yoo. (2016) The importance of assessment and management of morning stiffness in Asian patients with rheumatoid arthritis: Recommendations from an expert panel. International Journal of Rheumatic Diseases 19:1, pages 30-37.
Crossref
Qing YanQing Yan. 2016. Psychoneuroimmunology. Psychoneuroimmunology 27 35 .
Rieke Alten & Edgar Wiebe. (2015) Hypothalamic-Pituitary-Adrenal Axis Function in Patients with Rheumatoid Arthritis Treated with Different Glucocorticoid Approaches. Neuroimmunomodulation 22:1-2, pages 83-88.
Crossref
Qing YanQing Yan. 2015. Cellular Rhythms and Networks. Cellular Rhythms and Networks 71 81 .
Qing YanQing Yan. 2015. Cellular Rhythms and Networks. Cellular Rhythms and Networks 25 38 .
A. Kavanaugh & A. F. Wells. (2014) Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis. Rheumatology 53:10, pages 1742-1751.
Crossref
Gillian M. Keating, Sheridan Henness & Lily P. H. Yang. (2014) Modified-release prednisone: a guide to its use in rheumatoid arthritis. Drugs & Therapy Perspectives 30:8, pages 276-281.
Crossref
Kohsuke Yoshida, Teppei Hashimoto, Yoshitada Sakai & Akira Hashiramoto. (2014) Involvement of the Circadian Rhythm and Inflammatory Cytokines in the Pathogenesis of Rheumatoid Arthritis. Journal of Immunology Research 2014, pages 1-6.
Crossref
Anna Pia, Francesca Vignani, Gerhardt Attard, Marcello Tucci, Paolo Bironzo, Giorgio Scagliotti, Wiebke Arlt, Massimo Terzolo & Alfredo Berruti. (2013) Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone. Cancer Treatment Reviews 39:8, pages 966-973.
Crossref
Sheridan Henness & Lily P. H. Yang. (2013) Modified-Release Prednisone: in Patients with Rheumatoid Arthritis. Drugs 73:18, pages 2067-2076.
Crossref
Alvaro Arjona, Adam C. Silver, Wendy E. Walker & Erol Fikrig. (2012) Immunity's fourth dimension: approaching the circadian–immune connection. Trends in Immunology 33:12, pages 607-612.
Crossref
J. R. Kirwan & F. Buttgereit. (2012) Symptom control with low-dose glucocorticoid therapy for rheumatoid arthritis. Rheumatology 51:suppl 4, pages iv14-iv20.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.